Hungarian forint weakens as central bank cuts benchmark rate to record low

The Hungarian forint weakened against the dollar Tuesday after the country’s central bank lowered its benchmark interest rate to a record low. The currency , which has risen nearly 5% against the dollar so far this year amid a broader rally in developing markets, briefly tumbled to 277.52 to the dollar after the cut, compared with 276.73 late Monday in New York. It has since pared its decline to trade flat on the day. The central bank lowered its benchmark, the overnight lending rate, to 1.05%, from 1.20% previously. The central bank had already cut the rate once this year, at its previous meeting in March, when it also reduced its overnight deposit rate to an all-time low of minus 0.05%. By lower key interest rates, Hungary, Turkey and a host of other developing market economies are trying to ward off excessive currency strength as speculators search for return in a low interest rate environment.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Freeport-McMoRan’s results beat expectations, to cut 25% of oil and gas workforce

Freeport-McMoRan Inc. reported a first-quarter loss that widened to $4.18 billion, or $3.35 a share, from $2.47 billion, or $2.38 a share, in the same period a year ago. Excluding non-recurring items, the adjusted per-share loss was 16 cents, beating the FactSet consensus for a loss of 17 cents a share. Revenue fell to $3.53 billion from $4.15 billion, compared with the FactSet consensus of $3.51 billion, as a rise in copper sales volumes were offset by declines in gold, oil and gas and molybdenum sales. The mining company said it was cutting 25% of its oil and gas workforce, as well as institute a new management structure, as part of plans to cut costs. The company expects to record a $40 million charge in the second quarter related to the job cuts and restructuring. The stock, which was little changed in premarket trade, has soared 68% year to date, but was still down 45% over the past year. In comparison, the S&P 500 has gained 2.2% year to date, but has lost 1.4% the last 12 months.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Sarepta Therapeutics stock tanks after drug’s FDA committee review

Sarepta Therapeutics Inc. shares tumbled as much as 50% in active volume Tuesday morning after a Food and Drug Administration advisory committee voted against recommending FDA approval for the company’s Duchenne muscular dystrophy drug. The FDA, which does not have to follow the committee’s advice but often does, plans to review the drug May 26. DMD, a rare, inherited degenerative disorder that causes muscle loss and ususally death before the age of 30, affects about one in every 3,500 to 5,000 males globally. Patients and the families of patients with DMD have been actively lobbying for approval of the drug, eteplirsen, with many showing up to the committee meeting Monday. The company shares were the most active in pre-market trading Tuesday, after being halted for a full day, with trading resuming Tuesday at about 7:10 a.m.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

JetBlue shares rise on first-quarter earnings

Shares of JetBlue rose 4.7% Tuesday in premarket trade after the company beat first-quarter earnings expectations. The airline reported net income of $199 million, or 59 cents per share, up from $137 million, or 40 cents per share, in the year-earlier period. The FactSet consensus was for earnings per share of 53 cents. JetBlue reported revenue of $1.62 billion, up from $1.52 billion in the year-earlier period, but below the Factset consensus of $1.63 billion. Shares of JetBlue have fallen 10% year-to-date compared to the S&P 500’s gain of 2%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Hershey beats on earnings, provides downbeat outlook

Hershey Co. beat first-quarter EPS expectations but missed revenue projections, providing a downbeat 2016 earnings outlook. Earnings came in at $239 million, or $1.06 a share, compared with $243 million, or $1.10 a share in the same period a year ago. The company had adjusted EPS of $1.10 ahead of the FactSet consensus of $1.07. Revenue declined to $1.83 billion from $1.94 billion, compared with the FactSet consensus of $1.90 billion. For 2016, the company expects adjusted EPS of $4.24 to $4.28, below the FactSet consensus of $4.34. The stock gained 7.4% over the last three months, compared with a 9.7% rise in the S&P 500 .

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Procter & Gamble Co. sales fall, ‘tightens’ outlook

Procter & Gamble Co. shares are down 0.4% in premarket trading Tuesday, after the company announced third-quarter earnings that beat estimates, but offered a fourth-quarter outlook that will be “significantly lower” than last year. The consumer goods company had net income of $2.75 billion, or 97 cents per share, up from $2.15 billion, or 75 cents per share, for the same period last year. The FactSet consensus was 82 cents per share. Sales for the quarter totaled $15.76 billion, down from $16.93 billion last year, and just missing the FactSet consensus of $15.81 billion. The company said sales were negatively affected by foreign exchange, a 2% impact from Venezuela deconsolidation, and a 1% impact from minor brand divestitures. P&G sold its Duracell business during the quarter. The company expects total sales to be down high-single digits in fiscal 2016, and “tightened” its earnings expectations, forecasting a per-share decline between 3% and 6% versus $3.76 last year owing to advertising investments, a higher tax rate, headwinds from foreign exchange and lower non-operating income. P&G plans to repurchase and exchange shares worth $8 billion for the year. Shares are up 0.5% for the past year while the S&P 500 is down 1.4% for the same period.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Reynolds American profit boosted by gain on sale of American Spirit’s non-U.S. business

Reynolds American Inc. said Tuesday it had net income of $3.565 billion, or $2.49 a share, in the first quarter, up from $389 million, or $36 a share, in the year-earlier period. Income was boosted by a gain on the sale of Natural American Spirit’s business outside the U.S., offset by certain charges. Adjusted per-share earnings came to 50 cents, matching the FactSet consensus. Sales climbed to $2.917 billion from $2.057 billion, slightly below the FactSet consensus of $2.936 billion. The company said the integration of Newport manufacturing is on track for early completion by mid-2016, and that Chief Executive Susan Cameron will remain with the company to complete the integration of Lorillard and plan for her succession. “All of our operating companies demonstrated excellent performance, benefiting from increased volumes and higher pricing on both cigarettes and moist snuff,” she said in a statement.
The company is still expecting 2016 adjusted EPS to range from $2.25 to $2.35, compared with the FactSet consensus of $2.35. Shares were not yet active in premarket trade, but are up 4.9% in the year so far, while the S&P 500 has gained about 2%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Nokia shares rise 1.4% following digital health deal

Shares in Nokia Corp. gained 1.4% in early trading Tuesday after the Finnish tech company announced plans to buy Withings SA, saying the move will accelerate its entry into the digital health business. Withings, a French company with about 200 employees, makes activity trackers, blood pressure monitors, home and baby monitors, thermometers and other devices that link to mobile apps. The cash deal values Withings at 170 million euros, or about $192 million, and is expected to close in this year’s third quarter.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

United Technologies board hikes dividend 3%

United Technologies Corp. late Monday said its board hiked the company’s dividend by 3%. The new 66-cents-a-share dividend is payable June 10 to shareholders of record as of May 20. United Technologies shares were flat at $105.20 after hours.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Aratana shares jump on agreement with Lilly pet health unit

Aratana Therapeutics Inc. shares rallied in the extended session Monday after the animal-drug maker said it entered a licensing agreement with Eli Lilly & Co’s Elanco animal health unit. Aratana shares surged 19% to $8.23 after hours. The company said Elanco is paying the company $45 million upfront for a collaboration, licensing, and development agreement connected to the company’s Galliprant dog osteoarthritis treatment. Aratana said the agreement also comes with a $75 million payment if certain sales milestones are met, as well as royalty payments from Elanco.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News